Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-12-21
pubmed:abstractText
The aim of this study was to compare the efficacy and tolerability of vildagliptin vs. pioglitazone as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1463-1326
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
82-90
pubmed:dateRevised
2009-11-3
pubmed:meshHeading
pubmed-meshheading:18034842-Adamantane, pubmed-meshheading:18034842-Adolescent, pubmed-meshheading:18034842-Adult, pubmed-meshheading:18034842-Aged, pubmed-meshheading:18034842-Blood Glucose, pubmed-meshheading:18034842-Body Weight, pubmed-meshheading:18034842-Diabetes Mellitus, Type 2, pubmed-meshheading:18034842-Double-Blind Method, pubmed-meshheading:18034842-Drug Therapy, Combination, pubmed-meshheading:18034842-Female, pubmed-meshheading:18034842-Humans, pubmed-meshheading:18034842-Hypoglycemic Agents, pubmed-meshheading:18034842-Male, pubmed-meshheading:18034842-Metformin, pubmed-meshheading:18034842-Middle Aged, pubmed-meshheading:18034842-Nitriles, pubmed-meshheading:18034842-Pyrrolidines, pubmed-meshheading:18034842-Thiazolidinediones, pubmed-meshheading:18034842-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.
pubmed:affiliation
Section of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study